Heritability of angiotensin-converting enzyme and angiotensinogen: A comparison of US blacks and Nigerians

Hypertension

Volumn 35, Issue 5, 2000, Pages 1141-1147

  Cooper, Richard S ^a   Guo, Xiuqing ^a   Rotimi, Charles N ^a   Luke, Amy ^a   Ward, Ryk ^b   Adeyemo, Adebowale ^c   Danilov, Sergei M ^d  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF IBADAN   (Nigeria)

^d UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Angiotensin converting enzyme; Angiotensinogen; Blacks; Environment; Genes

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; ENVIRONMENTAL FACTOR; ENZYME BLOOD LEVEL; FAMILIAL DISEASE; FEMALE; GENETICS; HERITABILITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEGRO; OBESITY; PEDIGREE; PRIORITY JOURNAL; UNITED STATES;

EID: 0034085308     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.5.1141     Document Type: Article

References (37)

1. Ottman R. Gene-environment interactions: definitions and study designs. Prev Med. 1996;25:764-770.
2. Ottman R. An epidemiological approach to gene-environment interaction. Genet Epidemiol. 1990;7:177-185.
3. Khoury MJ, James LM. Population and familial relative risks of disease associated with environmental factors in the presence of gene-environment interaction. Am J Epidemiol. 1993;137:1241-1450.
4. Paterson AH, Damon S, Hewitt JD, Zamir D, Rabinowich HD, Lincoln SE, Lander ES, Tanksley SD. Mendelian factors underlying quantitative traits in tomato: comparison across species, generations, and environments. Genetics. 1991;127:181-197.
5. Lewontin R. Human Diversity. New York, NY: Scientific American Press; 1996.
6. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charm A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM. Molecular basis of human hypertension: role of angiotensinogen Cell. 1992;71: 169-180.
7. Rotimi C, Cooper R, Ogunbiyi O, Morrison L, Ladipo M, Tewksbury D, Ward R. Hypertension, serum angiotensinogen and molecular variants of the angiotensinogen gene among Nigerians. Circulation. 1997;95:2348-50.
8. Staessen JA, Kuznetsova T, Wang JG, Emelianov D, Vlietinck R, Fagard R. M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens. 1999;17:9-17.
9. Soubrier F. Blood pressure gene at the angiotensin I-converting enzyme locus: chronicle of a gene foretold. Circulation. 1998;97:1763-1765.
10. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, Clark AJL. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med. 1994;330:1629-1633.
11. Fornage M, Turner ST, Sing CF, Boerwinkle E. Variation at the M235T locus of the angiotensinogen gene and essential hypertension: a population-based case-control study from Rochester, Minnesota. Hum Genet. 1995;96:295-300.
12. Forrester T, McFarlane-Anderson N, Bennett FI, Wilks R, Cooper R, Rolimi C, Morrison L, Ward R. The insertion/deletion polymorphism of the ACE gene, serum ACE activity and blood pressure in Jamaicans. Am J Hypertens. 1997;10:519-522.
13. Alhenc-Gelas F, Costerousse O, Danliov S. Genetic and physiologic aspects of angiotensin I-converting enzyme. In: Kenny AJ, Boustead CM, eds. Cell Surface Peptides in Health and Disease. Oxford, UK: BIOS Scientific Publishers; 1997:119-135.
14. McKenzie C, Julier C, Forrester T, McFarlane-Anderson N, Keavney B, Lathrop GM, Ratcliffe PJ, Farrall M. Segregation and linkage analysis of serum angiotensin I-converting enzyme levels: evidence for two quantitative-trait loci. Am J Hum Genet. 1995;57:1426-1435.
15. Ward RH. Socio-cultural and genetic influences on the response of blood pressure to migration. Am J Phys Anthrop. 1984;62:91-105.
16. Ramirez ME, Brauer GW, Prior IAM, Ward RH. Biological variability in a migrating isolate: the Tokelau Islanders: child growth in different environments. Am J Hum Biol. 1991;3:189-210.
17. Blackburn R. The Making of the New World Slavery: From the Baroque to the Modern, 1492-1800. London. UK: Verso; 1997.
18. Harris JE. Global Dimensions of the African Diaspora. Washington, DC: Howard University Press; 1992.
19. Cavalli-Sforza LL, Cavalli-Sfzora F. The Great Human Diasporas. Reading, Mass: Addison-Wesley; 1995.
20. Cooper RS, Rotimi CN, Ward R. The puzzle of hypertension in African Americans. Sci Am. 1999;280:56-63.
21. Cooper R, Rotimi C, Ataman S, McGee D, Osotimehin B, Kadiri S, Muna W, Kingue S, Fraser H, Forrester T, Bennett F, Wilks R. Hypertension prevalence in seven populations of African origin. Am J Public Health. 1997;87:160-168.
22. Cooper R, Rotimi C, Kaufman JS, Owoaje EE. Fraser H, Forrester T, Wilks R, Riste LK, Cruickshank JK. Prevalence of NIDDM among populations of the African diaspora. Diabetes Care. 1997;20:343-348.
23. Luke A, Durazo-Arvizu R, Rotimi C, Prewitt TE, Forrester T, Ogunbiyi OJ, Owaje E, Schoeller DA, McGee D, Cooper RS. Relationship between body mass index and body fat in black population samples from Nigeria, Jamaica and the United States. Am J Epidemiol. 1997;145:620-628.
24. Ataman SL, Cooper R, Rotimi C, McGee D, Osotimehin B, Kadiri S, Kingue S, Muna W, Fraser H, Forrester T, Wilks R. Standardization of blood pressure measurement in an international comparative study. J Clin Epidemiol. 1996;49:869-877.
25. Rotimi R, Luke A, Li Z, Compton JA, Bowsher RR, Cooper RS. Familial aggregation of plasma leptin levels in African-American families. Genetic Epidemiol. 1997;14:255-263.
26. Rotimi CN, Cooper RS, Cao G, Ogunbiyi O, Ladipo M, Owoaje E, Ward R. Maximum likelihood generalized heritability estimates for blood pressure among Nigerian families. Hypertension. 1999;3:874-878.
27. Tewksbury DA, Dart RA. High molecular weight angiotensinogen levels in pregnant women. Hypertension. 1982;4:729-734.
28. Danilov S, Savoie F, Lenoir B, Jeunemaitre X, Azizi M, Tarnow L, Alhenc-Gelas F. Development of enzyme-linked immunoassays for human angiotensin I converting enzyme suitable for large-scale studies. J Hypertens. 1996;14:719-727.
29. SAS User's Guide Version 6. Cary, NC: SAS Institute; 1990.
30. S.A.G.E. Statistical Analysis for Genetic Epidemiology, release 3.1. Computer program package available from the Department of Epidemiology and Biostatistics, Rammelkamp Center for Education and Research, MetroHealth Campus, Case Western Reserve University, Cleveland, 1997.
31. Rice T, Despres JP, Daw EW, Gagnon J, Borecki IB, Perusse L, Leon AS, Skinner JS, Wilmore JH, Rao DC, Bouchard C. Familial resemblance for abdominal visceral fat: the HERITAGE family study. Int J Obes Relat Metab Disord. 1997;21:1024-1031.
32. Cambien F, Alhenc-Gelas F, Herbeth B, Andre JL, Rakotovao R, Gonzalez MF, Allegrini J, Bloch C. Familial resemblance of plasma angiotensin-converting-enzyme level: the Nancy Study. Am J Hum Genet. 1988;43:774-780.
33. Cooper R, Forrester T, Ogunbiyi O, Mufunda J. Angiotensinogen levels and obesity in four population samples. J Hypertens. 1998;16:571-576.
34. Cooper R, McFarlane-Anderson N, Bennet FI, Wilks R, Puras A, Tewksbury D, Morrison L, Forrester T. ACE, angiotensinogen and obesity: a potential pathway to hypertension. J Hum Hypertens. 1997;11: 107-112.
35. Alhenc-Gelas F, Richard J, Courbon D, Warnet JM, Corvol P. Distribution of plasma angiotensin I-converting enzyme levels in health men: relationship to environmental and hormonal parameters. J Lab Clin Med. 1991;117:33-39.
36. Ronday MJH, Van der Lelij A, Wienesen M, Rothova A, Stilma JS, Kiflstra A. Elevated serum angiotensin-converting enzyme activity in onchocerciasis. Lung. 1996;174:393-395.
37. Rice T, Province MA, Keller JB, Bouchard C, Higgins MW. Heterogeneity among populations for familial aggregation of blood pressure. Am J Hum Biol. 1991;3:515-523.